Neurocrine Biosciences
NBIX
#1312
Rank
NZ$29.82 B
Marketcap
NZ$296.63
Share price
-3.55%
Change (1 day)
35.14%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company